Cargando…

Adjuvant Anti-PD-1 Antibody Therapy for Advanced Melanoma: A Multicentre Study of 78 Japanese Cases

Anti-PD-1 antibodies (Abs) are among the optimal adjuvant therapies for melanoma at high risk of recurrence, especially BRAF wild-type melanoma, but the anti-tumour effects of anti-PD-1 Abs in the adjuvant setting for acral melanoma have not been evaluated previously. The aim of this study was to an...

Descripción completa

Detalles Bibliográficos
Autores principales:	MUTO, Yusuke, KAMBAYASHI, Yumi, KATO, Hiroshi, FUKUSHIMA, Satoshi, ITO, Takamichi, MAEKAWA, Takeo, FUJISAWA, Yasuhiro, YOSHINO, Koji, UCHI, Hiroshi, MATSUSHITA, Shigeto, YAMAMOTO, Yuki, AMAGAI, Ryo, OHUCHI, Kentaro, HASHIMOTO, Akira, FUJIMURA, Taku
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631249/ https://www.ncbi.nlm.nih.gov/pubmed/35670329 http://dx.doi.org/10.2340/actadv.v102.678

Ejemplares similares

Cutaneous angiosarcoma treated with taxane‐based chemoradiotherapy: A multicenter study of 90 Japanese cases
por: Fujimura, Taku, et al.
Publicado: (2022)

Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock
por: Muto, Yusuke, et al.
Publicado: (2020)

Serum CCL22 Increased in Advanced Melanoma Patients with Liver Metastases: Report of 5 Cases
por: Ohuchi, Kentaro, et al.
Publicado: (2022)

Quantitative Analysis of Immune-Reactive Cells among Leukocytes Is Useful for the Diagnosis of Drug Eruptions Caused by Bexarotene
por: Chiba, Hiromu, et al.
Publicado: (2022)

Recurrent, Tumor Mutation Burden-High, Cutaneous Angiosarcoma of the Scalp Treated with Pembrolizumab
por: Amagai, Ryo, et al.
Publicado: (2023)

Treatment of Advanced Melanoma: Past, Present and Future
por: Fujimura, Taku, et al.
Publicado: (2020)

Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy
por: Fujimura, Taku, et al.
Publicado: (2020)

Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2019)

Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients
por: Ohuchi, Kentaro, et al.
Publicado: (2021)

LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated Macrophages
por: Ohuchi, Kentaro, et al.
Publicado: (2023)

CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T‐cell lymphomas
por: Yamamoto, Jun, et al.
Publicado: (2023)

Pigmented Epithelioid Melanocytoma (Animal Types of Melanoma) on the Nose
por: Ohuchi, Kentaro, et al.
Publicado: (2018)

Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas
por: Fujimura, Taku, et al.
Publicado: (2021)

Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy
por: Yoshida, Saaya, et al.
Publicado: (2019)

Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma
por: Fujimura, Taku, et al.
Publicado: (2018)

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study
por: Fujimura, Taku, et al.
Publicado: (2018)

Tubulointerstitial Nephritis in an Advanced Melanoma Patient Treated with Encorafenib plus Binimetinib Combination Therapy
por: Kambayashi, Yumi, et al.
Publicado: (2022)

Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside
por: Fujimura, Taku, et al.
Publicado: (2019)

Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection
por: Fujimura, Taku, et al.
Publicado: (2019)

Keratoacanthoma Centrifugum Marginatum with Spontaneous Regression and Its Possible Differential Diagnosis
por: Amagai, Ryo, et al.
Publicado: (2018)

Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
por: Fujimura, Taku, et al.
Publicado: (2018)

Variable indoleamine 2,3‐dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy
por: Iga, Natsuko, et al.
Publicado: (2019)

Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy
por: Sato, Yota, et al.
Publicado: (2018)

Matrix Metalloproteinase 28-Bearing Microcystic Adnexal Carcinoma on the Back
por: Chiba, Hiromu, et al.
Publicado: (2021)

IL-23 Expression in Stewart-Treves Syndrome: Two Case Reports and Immunohistochemical Investigation
por: Yoshida, Saaya, et al.
Publicado: (2020)

Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy
por: Kambayashi, Yumi, et al.
Publicado: (2020)

Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
por: Fujimura, Taku, et al.
Publicado: (2012)

Systemic therapy for Asian patients with advanced BRAF V600‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (B‐CHECK‐RWD study)
por: Namikawa, Kenjiro, et al.
Publicado: (2023)

Basosquamous Cell Carcinoma Developing from a Renal Transplantation Recipient
por: Tsukada, Akira, et al.
Publicado: (2012)

Successful Treatment of Eccrine Porocarcinoma Metastasized to a Cervical Lymph Node with CyberKnife Radiosurgery
por: Fujimura, Taku, et al.
Publicado: (2014)

Keratoacanthoma Accompanied by Multiple Lung Squamous Cell Carcinomas Developing in a Renal Transplant Recipient
por: Furudate, Sadanori, et al.
Publicado: (2014)

Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities
por: Furudate, Sadanori, et al.
Publicado: (2016)

Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
por: Amagai, Mayuko, et al.
Publicado: (2022)

Therapy-Resistant, Spontaneously Remitting Generalized Neutrophilic Eccrine Hidradenitis in a Healthy Patient Decreases the Expression of Dermcidin in Affected Eccrine Glands
por: Kambayashi, Yumi, et al.
Publicado: (2011)

Basal Cell Carcinoma with Spontaneous Regression: A Case Report and Immunohistochemical Study
por: Fujimura, Taku, et al.
Publicado: (2012)

Profiles of Cytotoxic T Lymphocytes in Cutaneous Lymphoid Hyperplasia of the Face
por: Furudate, Sadanori, et al.
Publicado: (2013)

Potential Use of Bisphosphonates in Invasive Extramammary Paget's Disease: An Immunohistochemical Investigation
por: Fujimura, Taku, et al.
Publicado: (2013)

Granulysin-Bearing Cells in the Skin Lesions of Acute Graft-versus-Host Disease: Possible Mechanisms for Hypohidrosis in Graft-versus-Host Disease
por: Furudate, Sadanori, et al.
Publicado: (2013)

Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies
por: Kambayashi, Yumi, et al.
Publicado: (2019)

Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab
por: Tanita, Kayo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vuqg3vklb6evevhcaptqaha76a